vs

Side-by-side financial comparison of Enact Holdings, Inc. (ACT) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $312.7M, roughly 1.6× Enact Holdings, Inc.). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 3.6%).

Enact Holdings, Inc. is a leading U.S.-based private mortgage insurance provider. It delivers risk mitigation solutions to residential mortgage lenders, banks, and credit unions, enabling borrowers with smaller down payments to access affordable home financing, and supports sustainable homeownership for diverse consumer groups across the United States.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

ACT vs GENI — Head-to-Head

Bigger by revenue
GENI
GENI
1.6× larger
GENI
$510.9M
$312.7M
ACT
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
3.6%
ACT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACT
ACT
GENI
GENI
Revenue
$312.7M
$510.9M
Net Profit
$-63.0M
Gross Margin
25.2%
Operating Margin
71.3%
-11.5%
Net Margin
-12.3%
Revenue YoY
3.6%
Net Profit YoY
EPS (diluted)
$1.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACT
ACT
GENI
GENI
Q4 25
$312.7M
$510.9M
Q3 25
$311.5M
$335.4M
Q2 25
$304.9M
$215.2M
Q1 25
$306.8M
$119.7M
Q4 24
$301.8M
$413.0M
Q3 24
$309.6M
$285.8M
Q2 24
$298.8M
$184.1M
Q1 24
$291.6M
$97.2M
Net Profit
ACT
ACT
GENI
GENI
Q4 25
$-63.0M
Q3 25
Q2 25
$-47.3M
Q1 25
$-25.5M
Q4 24
$-85.5M
Q3 24
$-47.1M
Q2 24
$-35.5M
Q1 24
$-25.2M
Gross Margin
ACT
ACT
GENI
GENI
Q4 25
25.2%
Q3 25
24.2%
Q2 25
19.1%
Q1 25
10.7%
Q4 24
16.7%
Q3 24
20.5%
Q2 24
18.6%
Q1 24
9.8%
Operating Margin
ACT
ACT
GENI
GENI
Q4 25
71.3%
-11.5%
Q3 25
67.4%
-15.3%
Q2 25
70.4%
-21.0%
Q1 25
68.9%
-20.3%
Q4 24
68.9%
-18.0%
Q3 24
74.1%
-13.9%
Q2 24
78.6%
-16.8%
Q1 24
70.6%
-23.7%
Net Margin
ACT
ACT
GENI
GENI
Q4 25
-12.3%
Q3 25
Q2 25
-22.0%
Q1 25
-21.3%
Q4 24
-20.7%
Q3 24
-16.5%
Q2 24
-19.3%
Q1 24
-25.9%
EPS (diluted)
ACT
ACT
GENI
GENI
Q4 25
$1.23
Q3 25
$1.10
Q2 25
$1.11
Q1 25
$1.08
Q4 24
$1.05
Q3 24
$1.15
Q2 24
$1.16
Q1 24
$1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACT
ACT
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$582.5M
$280.6M
Total DebtLower is stronger
$744.5M
Stockholders' EquityBook value
$5.4B
$724.5M
Total Assets
$6.9B
$1.1B
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACT
ACT
GENI
GENI
Q4 25
$582.5M
$280.6M
Q3 25
$545.6M
$110.2M
Q2 25
$616.0M
$110.2M
Q1 25
$639.0M
$110.2M
Q4 24
$602.8M
$100.3M
Q3 24
$674.9M
$100.3M
Q2 24
$711.3M
$100.3M
Q1 24
$624.3M
$100.3M
Total Debt
ACT
ACT
GENI
GENI
Q4 25
$744.5M
Q3 25
$744.1M
Q2 25
$743.8M
Q1 25
$743.4M
Q4 24
$743.0M
Q3 24
$742.7M
Q2 24
$742.4M
Q1 24
$746.1M
Stockholders' Equity
ACT
ACT
GENI
GENI
Q4 25
$5.4B
$724.5M
Q3 25
$5.3B
$572.4M
Q2 25
$5.2B
$572.4M
Q1 25
$5.1B
$572.4M
Q4 24
$5.0B
$573.0M
Q3 24
$5.0B
$573.0M
Q2 24
$4.8B
$573.0M
Q1 24
$4.7B
$573.0M
Total Assets
ACT
ACT
GENI
GENI
Q4 25
$6.9B
$1.1B
Q3 25
$6.9B
$792.3M
Q2 25
$6.8B
$792.3M
Q1 25
$6.7B
$792.3M
Q4 24
$6.5B
$775.7M
Q3 24
$6.6B
$775.7M
Q2 24
$6.3B
$775.7M
Q1 24
$6.3B
$775.7M
Debt / Equity
ACT
ACT
GENI
GENI
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.14×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.15×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACT
ACT
GENI
GENI
Operating Cash FlowLast quarter
$724.5M
$81.9M
Free Cash FlowOCF − Capex
$69.6M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACT
ACT
GENI
GENI
Q4 25
$724.5M
$81.9M
Q3 25
$192.0M
$-4.8M
Q2 25
$119.5M
$-1.2M
Q1 25
$226.7M
$-14.6M
Q4 24
$686.3M
$14.9M
Q3 24
$188.1M
$-9.2M
Q2 24
$144.7M
Q1 24
$187.3M
Free Cash Flow
ACT
ACT
GENI
GENI
Q4 25
$69.6M
Q3 25
$-14.2M
Q2 25
$-5.8M
Q1 25
$-16.0M
Q4 24
$11.3M
Q3 24
$-11.6M
Q2 24
Q1 24
FCF Margin
ACT
ACT
GENI
GENI
Q4 25
13.6%
Q3 25
-4.2%
Q2 25
-2.7%
Q1 25
-13.4%
Q4 24
2.7%
Q3 24
-4.1%
Q2 24
Q1 24
Capex Intensity
ACT
ACT
GENI
GENI
Q4 25
2.4%
Q3 25
2.8%
Q2 25
2.1%
Q1 25
1.2%
Q4 24
0.9%
Q3 24
0.9%
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons